Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
Watch CBS News
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
The governor says nearly everyone should get the new vaccine, even if they never got the old one. CBS New York's Jessica Moore reports on her briefing.
Federal health officials say thousands of updated booster shots are already being shipped around the country.
New COVID booster shots targeting the highly contagious Omicron variant could soon be available. The FDA has authorized Pfizer and Moderna shots. Nancy Chen reports for CBS2.
The Biden administration has reached a deal to buy $66 million doses of Moderna's new COVID vaccine booster that targets the Omicron variant.
The CDC authorized the shots over the weekend and now they are available to roughly 20 million children in the U.S.
Mayor Eric Adams and Health Commissioner Dr. Ashwin Vasan toured a site ahead of its opening in Times Square, reassuring parents the vaccines are safe and effective.
COVID vaccines for children as young as six months old are now available across New York City. CBS2's Elijah Westbrook speaks with parents to see their reactions.
With COVID vaccines now available for children under 5, we speak with an expert about safety and efficacy.
COVID vaccines for children as young as six months old are being made available across the city. CBS2's Elijah Westbrook has more.
The city said it planned to start taking appointments for the Moderna and Pfizer shots starting at around 9 p.m. on Tuesday. CBS2's Natalie Duddridge reports.
The Pfizer and Moderna vaccines now head to the CDC for final approval.
The CDC says more than 440 children ages 4 and under have died from COVID during the pandemic.
If approved, kids could get shots as early as next week. CBS2's Natalie Duddridge has the latest.
The FDA is meeting today to decide whether to approve the Pfizer and Moderna vaccines for children as young as six months old.
It comes as the city's health commissioner says New York has passed the peak of a COVID wave.
The FDA has pledged to "move with all expediency" to review the company's data on a lower-dose kids' vaccine.
Right now, only children ages 5 and older can get the COVID-19 vaccine in the U.S. But that could soon change.
Moderna on Thursday submitted a request to the FDA for emergency use authorization for two low-dose COVID vaccines for babies and children under 5. CBS2's Jenna DeAngelis spoke to a Long Island family involved in the clinical trial.
The company asked the FDA to authorize a lower dose of its COVID vaccine for children 5 and under.
As CBS2's Elijah Westbrook reports, the FDA has authorized a second COVID booster shot for people over 50. But for anyone without insurance, the vaccine, as well as testing, could now cost you.
The FDA has authorized a second booster of Moderna or Pfizer as early as four months after receiving first one.
Breaking news for people who got the Pfizer and Moderna vaccines.
In a long-awaited development, Moderna says it will ask for emergency authorization of its coronavirus vaccine for children under 6. Now, it's up to regulators to decide if the pediatric doses are safe and effective; CBS2's Dr. Max Gomez reports.
The company says its lower dose shot is effective in kids under 6. CBS2's Dr. Max Gomez explains.
